A. Data Definition Tables

Empfehlungen

Info

Appendix A: Data Definition Tables Type Table Name Value Description Bezeichnung 0237 W Drug withdrawal 0237 B Unexpected beneficial effect HL7 0238 Event Seriousness 0238 Y Yes 0238 S Significant 0238 N No HL7 0239 Event Expected 0239 Y Yes 0239 N No 0239 U Unknown HL7 0240 Event Consequence 0240 D Death 0240 L Life threatening 0240 H Caused hospitalized 0240 P Prolonged hospitalization 0240 C Congenital anomaly/birth defect 0240 I Incapacity which is significant, persistent or permanent 0240 J Disability which is significant, persistent or permanent 0240 R Required intervention to prevent permanent impairment/damage 0240 O Other HL7 0241 Patient Outcome 0241 D Died 0241 R Recovering 0241 N Not recovering/unchanged 0241 W Worsening 0241 S Sequelae 0241 F Fully recovered 0241 U Unknown HL7 0242 Primary Observer's Qualification 0242 P Physician (osteopath, homeopath) 0242 R Pharmacist 0242 M Mid-level professional (nurse, nurse practitioner, physician's assistant) 0242 H Other health professional 0242 C Health care consumer/patient 0242 L Lawyer/attorney 0242 O Other non-health professional HL7 0243 Identity may be Divulged 0243 Y Yes 0243 N No 0243 NA Not applicable User 0244 Single Use Device 0244 No suggested values User 0245 Product Problem 0245 No suggested values User 0246 Product Available for Inspection 0246 No suggested values HL7 0247 Start of Evaluation 0247 Y Evaluation completed 0247 P Evaluation in progress 0247 K Problem already known, no evaluation necessary 0247 X Product not made by company 0247 A Evaluation anticipated, but not yet begun 0247 D Product discarded -- unable to follow up 0247 C Product received in condition Page A-44 Health Level Seven, Version 2.3 © 1997. All rights reserved. 1/24/02 Final Standard.
Type Table Name Value Description Bezeichnung which made analysis impossible 0247 I Product remains implanted -- unable to follow up 0247 U Product unavailable for follow up investigation 0247 Q Product under quarantine -- unable to follow up 0247 R Product under recall/corrective action 0247 O Other HL7 0248 Product Source 0248 A Actual product involved in incident was evaluated 0248 L A product from the same lot as the the actual product involved was evaluated 0248 R A product from a reserve sample was evaluated 0248 N A product from a controlled/nonrelated inventory was evaluated User 0249 Generic Product 0249 No suggested values HL7 0250 Relatedness Assessment 0250 H Highly probable 0250 M Moderately probable 0250 S Somewhat probable 0250 I Improbable 0250 N Not related HL7 0251 Action Taken in Response to the Event 0251 WP Product withdrawn permanently 0251 WT Product withdrawn temporarily 0251 DR Product dose or frequency of use reduced 0251 DI Product dose or frequency of use increased 0251 OT Other 0251 N None HL7 0252 Causality Observations 0252 AW Abatement of event after product withdrawn 0252 BE Event recurred after product reintroduced 0252 LI Literature reports association of product with event 0252 IN Event occurred after product introduced 0252 EX Alternative explanations for the event available 0252 PL Effect observed when patient receives placebo 0252 TC Toxic levels of product documented in blood or body fluids 0252 DR Dose response observed 0252 SE Similar events in past for this patient 0252 OE Occurrence of event was confirmed by objective evidence 0252 OT Other HL7 0253 Indirect Exposure Mechanism 0253 B Breast milk 0253 P Transplacental 0253 F Father Appendix A: Data Definition Tables Health Level Seven, Version 2.3 © 1997. All rights reserved. Page A-45 Final Standard. 1/24/02
Seite 1 und 2: A.1 INTRODUCTION A. Data Definition
Seite 3 und 4: Appendix A: Data Definition Tables
Seite 5 und 6: Segment Description Chapter OBX Obs
Seite 41 und 42: Type Table Name Value Description B
Seite 43: Type Table Name Value Description B
Seite 91: Appendix A: Data Definition Tables

A. Data Definition Tables

Sie wollen auch ein ePaper? Erhöhen Sie die Reichweite Ihrer Titel.

Template löschen?

Als Template speichern?